MaxBetto
< Back

Veronika Erjavec vs Alina Charaeva

Tennis
2025-09-13 15:30
Start: 2025-09-14 01:00

Summary

Pick: away
EV: 0.248

Current Odds

Home 1.38|Away 3.27
Best Odds

Match Info

Match key: Veronika Erjavec_Alina Charaeva_2025-09-14

Analysis

Summary: We see value on Alina Charaeva at 2.6 because the market overprices the favorite relative to the symmetric profiles; at an estimated 48% win chance the away price yields ~+0.248 EV.

Highlights

  • Home implied probability (1.521) ≈ 65.7% — appears overstated given provided data
  • Away at 2.6 implies 38.5% but we estimate closer to 48%, creating value

Pros

  • + Current away price (2.6) is comfortably above our min required odds (2.083)
  • + Decision grounded on parity in supplied performance data—no clear edge for favorite

Cons

  • - Research supplied is sparse and shows nearly identical records, increasing model uncertainty
  • - Tournament/context-specific factors (matchup details, H2H, on-site conditions) are not present in the data

Details

The market prices Veronika Erjavec as a clear favorite at 1.521 (implied ~65.7%) while Alina Charaeva is available at 2.6 (implied ~38.5%). The available profiles show nearly identical career records, surfaces played and recent results, indicating there is no strong performance-based justification for a >25-point gap in win probability. Given symmetry in the provided data and no clear injury or form edge, we estimate the true win probability for Charaeva materially above the market-implied 38.5% (we estimate ~48%). At that true probability the away line (2.6) offers positive expected value: EV = 0.48*2.6 - 1 = +0.248. In contrast the favorite is over-priced relative to our estimate (EV negative at current 1.521). Therefore we recommend the away side as a value play at the quoted price.

Key factors

  • Both player profiles show nearly identical records, surfaces and recent results in the supplied data
  • Market-implied probability for the away player (≈38.5%) appears too low given parity in profiles
  • No listed injuries or clear form advantage for the favorite in the provided research